The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like <b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017 Isogenica Limited Introduces Next-Generation, Fully Synthetic Human Fab Antibody Fragment Library May 2, 2017 Biotech Unicorn Moderna Details Game Plan, Reveals Infectious Disease Programs January 9, 2018
<b>John Adamou</b> Named Vice President Of Corporate & Business Development At <b>rHEALTH</b> And <b>DNA Medicine Institute</b> January 30, 2017
Isogenica Limited Introduces Next-Generation, Fully Synthetic Human Fab Antibody Fragment Library May 2, 2017